FLIGHTPATH BIOSCIENCES, INC.;RAJADAS, Jayakumar;INAYATHULLAH NAZIR AHMED, Mohammed;SURYA KUMAR POTULA, Hari Hara;POTHINENI, Venkata Raveendra
发明人:
TINDALL, Matthew Charles,BALAKRISHNAN, Vijaya
申请号：
USUS2020/016708
公开号：
WO2020/163425A1
申请日:
2020.02.05
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed herein are pharmaceutical formulations which include disulfiram and/or azlocillin for the treatment of diseases such as Lyme disease and Lyme disease related disorders including post- treatment Lyme disease syndrome (PTLDS), chronic Lyme disease (CLD) and/or inflammation.L'invention concerne des formulations pharmaceutiques qui comprennent du disulfirame et/ou de l'azlocilline pour le traitement de maladies telles que la maladie de Lyme et les troubles liés à la maladie de Lyme dont le syndrome post-traitement de la maladie de Lyme (PTLDS), la maladie de Lyme chronique (CLD) et/ou l'inflammation.
